BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013

Mar 14, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-01-31

Reporting Person: Sheridan William P (SR VP - CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-31	Common Stock	A	3000	$1.38	Acquired	67656	Direct

Footnotes

F1: Acquisition of securities pursuant to the issuer's Employee Stock Purchase Plan; exempt under Rule 16b-3(c).